黃夾次苷
外觀
臨床資料 | |
---|---|
其他名稱 | (3S,5R,10R,13R,14S,17R)- 3-[(2S,5R)- 3,5-dihydroxy- 4-methoxy- 6-methyloxan- 2-yl]oxy- 14-hydroxy- 13-methyl- 17-(5-oxo-2H-furan-3-yl)- 1,2,3,4,5,6,7,8,9,11,12,15,16,17- tetradecahydrocyclopenta[a]phenanthrene- 10-carbaldehyde |
ATC碼 | |
識別資訊 | |
| |
CAS號 | 1182-87-2 |
PubChem CID | |
ChemSpider | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.013.327 |
化學資訊 | |
化學式 | C30H44O9 |
摩爾質量 | 548.665 g/mol |
3D模型(JSmol) | |
| |
|
黃夾次苷(英語:Peruvoside或稱為黃花夾竹桃苷,英語:cannogenin thevetoside)是一種強心苷[1],用於治療心臟衰竭[2],來源於黃花夾竹桃(學名:Cascabela thevetia,曾用學名:Thevetia neriifolia)[2]。
參考文獻
[編輯]- ^ Arora, R. B.; Rangaswami, S. Peruvoside and Other Cardiotonic Glycoside[s] of Thevetia neriifolia Juss: Chemical, Pharmacological, and Clinical Studies. New Delhi, India: Thomson. 1972. LCCN 78900408.
- ^ 2.0 2.1 Bhatia, M. L.; Manchanda, S. C.; Roy, S. B. Haemodynamic Studies with Peruvoside in Human Congestive Heart Failure. British Medical Journal. 1970, 3 (5725): 740–743. PMC 1701679 . PMID 4919553. doi:10.1136/bmj.3.5725.740.
這是一篇關於有機化合物的小作品。您可以透過編輯或修訂擴充其內容。 |